Posts Tagged: Ontario Centres of Excellence (OCE)

LegWorks takes top spot at Parapan Am accessibility tech pitch contest

BresoTec, formerly known as ApneaDx, also among top five finalists TORONTO, August 11, 2015 – Legworks' next-generation prosthetic knee took first place in Ontario Centres of Excellence’s (OCE’s) Parapan Am Games-affiliated Accessibility Tech Pitch competition. The company immediately said it would use the $20,000 award to fit 200 amputees in developing countries with its device. Legworks was selected from 18 participants in a two-day elimination pitch competition – one of the features of the Government of Ontario’s Accessibility Innovation Showcase held at MaRS ... Read more

Call for Applications: MSc Proof-of-Principle Program

The Medical Sciences Proof-of-Principle (MSc PoP) program, administered by Ontario Centres of Excellence on behalf of Ontario's Ministry of Research & Innovation, is a province-wide initiative for which MaRS Innovation accepts applications from our 15 member institutions. MaRS Innovation is currently recruiting applications for the July 30, 2015 August 27, 2015 (2 pm) deadline; for submissions to be considered via MI, paperwork must be in byAugust 24, 2015 (4 pm). We've also learned there will be a second call for MScPoP applications in ... Read more

Encycle Therapeutics working with major pharmaceutical companies to design rules for drugs meant to be swallowed

CQDM and MaRS Innovation investing in new Encycle project to determine rules for making peptide drugs orally bioavailable PHILADELPHIA (June 16, 2015) — FiercePharma has predicted that the pharmaceutical industry stands to lose $44 billion in drugs going off patent in 2015. The industry is searching for new therapeutics to replenish their pipelines while tackling existing and new drug receptor targets within the cell, improve patient care and lower administrative costs. In this context, drugs that can be orally swallowed, known as ... Read more

Ontario Government Invests $1 Million in Toronto’s Neuroscience Catalyst Consortium

Ministry of Research & Innovation joins founding partners University of Toronto and Janssen Inc., and new partners Evotec AG, MaRS Innovation and Ontario Centres of Excellence, to advance treatments for neurological disorders and develop early-stage biotech companies TORONTO and PHILADELPHIA (June 16, 2015)— Toronto’s neuroscience efforts to find new drugs to treat and manage brain disorders — specifically, mood disorders and Alzheimer's disease — took another step forward as the Government of Ontario’s Ministry of Research and Innovation announced a $1 million ... Read more

ChipCare closes oversubscribed $5 million series A financing

With lead investment from Puffin Partners, the Ontario, Canada-based company is taking lifesaving blood-testing technology to low- and middle-income countries TORONTO, March 3, 2015 — ChipCare Corporation, a University of Toronto start-up company commercializing a handheld, blood-testing platform for HIV and other infectious and non-communicable diseases has closed a $5.045 million Series A financing to bring its first-generation product to market while further developing the platform’s next generation products. The Wall Street Journal's Venture Capital Dispatch blog, Yonge Street Media, BetaKit and PEHub ... Read more

BlueDot, formerly BioDiaspora Inc., secures Series A with Horizons Ventures

Toronto-based commercial arm of BioDiaspora research program tracks global spread of infectious diseases in real-time; fourth MI company to reach Series A TORONTO (Dec. 2, 2014) — BlueDot, a Toronto-based social benefit corporation founded by Dr. Kamran Khan, an infectious disease physician and scientist, tracks and predicts the global spread of infectious diseases. Spun off from St. Michael’s Hospital in partnership with MaRS Innovation (and formerly known as BioDiaspora Inc.), BlueDot, has secured a Series A venture capital funding from Horizons Ventures. Funded ... Read more

Holland Bloorview’s Anxiety Meter included in Globe and Mail’s neuroscience feature

"Research labs across Ontario are full of ingenious – and even life-saving – inventions. Unfortunately, many of them never make it to market," writes Wendy Leung in "These six great neuroscience ideas could make the leap from lab to market" in the November 20, 2014 edition of the Globe and Mail. MaRS Innovation, which was created to help researchers solve exactly this problem, has a project with Holland Bloorview Kids Rehabilitation Hospital that was featured in Leung's article. Asim Siddiqi founded the anxiety ... Read more

UTEST grad TrendMD makes Canadian national media splash

TrendMD, a medical publishing company that helps doctors, researchers, and professionals in STEM-related fields to find the most relevant content amid an unending sea of daily publications, was recently featured in a Canadian Press article by Adam Miller. The article was published on CBC.ca, CTV.ca, Waterloo Record, Sing Tao Daily, World Journal, Surrey Leader, Metro News, Winnipeg Free Press, Brampton Guardian, Ottawa Citizen, 660 News Radio, Canadian Business, Times Colonist, Yahoo News, Soo Today, Lethbridge Herald and YorkRegion.com, among other sources. The company is ... Read more

MaRS Innovation joins new financing round for AvidBiologics Inc.

TORONTO, Sept. 29, 2014 — AvidBiologics Inc., an oncology drug development company, today announced the closing of a financing round. The company is founded on antibody-drug conjugate (ADC) technologies co-developed with the National Research Council of Canada (NRC). Led by Lumira Capital, the financing round included MaRS Innovation (MI), MaRS Investment Accelerator Fund (IAF), Rosseau Asset Management, and the company's founding investors. This announcement was covered by Dow Jones: Private Equity and Venture Capital and by Canadian Private Equity. Today's financing builds on prior ... Read more

MI’s Fanny Sie to speak about 3D printing trends at two Toronto events

Fanny Sie, MaRS Innovation's head of imaging technologies and a manager in the Technology & Venture Development group, is speaking about bioprinting trends at two Toronto conferences this weekend. Sie is MI's commercialization lead on the Bioprinter, a licensenable technology from the University of Toronto and Sunnybrook Health Sciences Centre. Watch her interview on bioprinting with TVO's The Agenda, which aired in June 2013. First up is Digifest, an international festival celebrating digital creativity, which runs from May 8 to 10 at the Corus ... Read more
Page 2 of 512345